Product
APL-1501
1 clinical trial
1 indication
Indication
Healthy Control ParticipantsClinical trial
A Phase 1, Open-Label, Randomized, Crossover Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of APL-1501 ER Capsules Compared to APL-1202 IR Tablets in Healthy VolunteersStatus: Not yet recruiting, Estimated PCD: 2024-08-21